ESOPHAGEAL or GASTROESOPHAGEAL JUNCTION EA2174
Study #EA2174A Phase II / III Study of Peri-Operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
Back To Clinical Trials NCI Database Entry